Mustang Bio (MBIO) Interest & Investment Income (2016 - 2026)
Mustang Bio (MBIO) posted quarterly Interest & Investment Income of $103000.0 for Q1 2026, up 3.0% year-over-year from $100000.0 in Q1 2025, and down 21.97% quarter-over-quarter from $132000.0 in Q4 2025.
Mustang Bio (MBIO) Interest & Investment Income (2016 - 2026) Analysis & Trends
Mustang Bio (MBIO) has reported Interest & Investment Income for 11 consecutive years, with $103000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Interest & Investment Income rose 3.0% year-over-year to $103000.0; the TTM figure through Mar 2026 stood at $514000.0 (up 115.06% YoY), while the FY2025 annual figure was $511000.0, up 185.47% from the prior year.
- Interest & Investment Income slipped to $103000.0 in Q1 2026 per MBIO's latest filing, from $132000.0 in the prior quarter.
- Across five years, Interest & Investment Income topped out at $453000.0 in Q1 2023 and bottomed at $27000.0 in Q2 2024.
- Historically, Interest & Investment Income has averaged $137176.5 across 5 years, with a median of $115000.0 in 2023.
- Annual changes were most pronounced in 2023 — Interest & Investment Income jumped 520.55% — and 2024, when it sank 91.17%.
- Mustang Bio's Interest & Investment Income stood at $323000.0 in 2022, then slumped by 61.92% to $123000.0 in 2023, then slumped by 47.15% to $65000.0 in 2024, then jumped by 103.08% to $132000.0 in 2025, then retreated by 21.97% to $103000.0 in 2026.
- Business Quant data shows MBIO's Interest & Investment Income at $103000.0 in Q1 2026, $132000.0 in Q4 2025, and $156000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 120.60 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -48.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 48.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 67.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 27.90 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 28.14 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 115.94 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 10.98 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 5.13 Mn |
| 10 | Mustang Bio | 3.90 Mn | 3.90 Mn | - | 98,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 98,000.00 |
| Mar 31, 2026 | 103,000.00 |
| Dec 31, 2025 | 132,000.00 |
| Sep 30, 2025 | 156,000.00 |
| Jun 30, 2025 | 123,000.00 |
| Mar 31, 2025 | 100,000.00 |
| Dec 31, 2024 | 65,000.00 |
| Sep 30, 2024 | 47,000.00 |
| Jun 30, 2024 | 27,000.00 |
| Mar 31, 2024 | 40,000.00 |
| Dec 31, 2023 | 123,000.00 |
| Sep 30, 2023 | 115,000.00 |
| Jun 30, 2023 | 159,000.00 |
| Mar 31, 2023 | 453,000.00 |
| Dec 31, 2022 | 323,000.00 |
| Sep 30, 2022 | 216,000.00 |
| Jun 30, 2022 | 77,000.00 |
| Mar 31, 2022 | 73,000.00 |
| Dec 31, 2021 | 74,000.00 |
| Sep 30, 2021 | 75,000.00 |